Hypothesis\n\nIn aged males, downregulated MSH2/MSH6 impairs the error‑free processing of AID‑generated uracil lesions during somatic hypermutation, leading to persistent U:G mismatches that activate the ATR‑CHK1‑p53 axis and trigger apoptosis of germinal‑center B cells. This sex‑biased loss of compounds the global AID suppression driven by PP2A‑mediated E47 instability, producing a two‑hit mechanism that disproportionately contracts the naive and antigen‑experienced repertoire in elderly men and explains their lower vaccine‑induced affinity maturation.\n\n## Mechanistic Rationale\n\n- AID deaminates cytosine to uracil in immunoglobulin variable regions; in young B cells, MSH2/MSH6‑dependent mismatch repair recruits error‑prone polymerases to generate diversity.\n- When MSH2/MSH6 are deficient (as observed in aged males)[https://pmc.ncbi.nlm.nih.gov/articles/PMC8582005/], uracil persists, is recognized by the mismatch repair‑independent base excision repair (BER) pathway, and can generate single‑strand breaks that, if unrepaired, stall replication forks.\n- Stalled forks activate ATR‑CHK1 signaling, stabilizes p53, and upregulates pro‑apoptotic genes (BAX, PUMA). We propose that this DNA‑damage checkpoint selectively eliminates B cells undergoing intense SHM, biasing the surviving repertoire toward low‑mutation clones.\n- PP2A‑driven E47 downregulation reduces AID transcription globally[https://pmc.ncbi.nlm.nih.gov/articles/PMC5673119/]; thus, aged males suffer both fewer AID‑initiated lesions and a higher probability that any lesion becomes lethal.\n\n## Testable Predictions\n\n1. Flow cytometry of splenic germinal‑center B cells from aged male and female mice will show increased Annexin V+/7‑AAD− apoptosis specifically in GL7+FAS+ cells males, correlating with low MSH2/MSH6 expression.\n2. Genetic rescue: B‑cell‑specific overexpression of MSH2 in aged male mice will restore SHM frequency (measured by Sanger sequencing of IgV regions) and improve neutralizing antibody titers after H1N1 vaccination to levels comparable with aged females.\n3. Pharmacologic inhibition of ATR (e.g., VE‑822) in aged male B‑cell cultures will reduce apoptosis without affecting AID expression, increasing clonal diversity in vitro.\n4. Single‑cell multi‑omics (scRNA‑seq + scVDJ) from elderly human donors will reveal a male‑biased enrichment of transcriptional signatures of p53 activation and reduced clonal expansion indices.\n\n## Falsifiability\n\nIf aged male B cells do not exhibit higher apoptosis linked to MSH2/MSH6 loss, or if restoring MSH2 fails to improve SHM or vaccine responses, the hypothesis would be refuted, indicating that sex‑biased repair deficits operate through alternative mechanisms (e.g., altered cytokine signaling).\n\n## Broader Impact\n\nLinking metabolic (ELOVL2), phosphatase (PP2A), and sex‑specific DNA repair pathways provides a unified framework for why elderly men suffer disproportionate vaccine failure and suggests combined targeting of PP2A (to raise AID) and ATR/p53 (to rescue survival) as a sex‑tailored rejuvenation strategy.